JPRN-UMIN000023496已完成未知
A study for evaluating the effect of the intake of food containing HYA on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial - A study for evaluating the effect of the intake of food containing HYA
TTC Co., Ltd0 个研究点目标入组 60 人开始时间: 2016年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
Compared with the placebo, low- and high-dose HYA showed a significant suppress the AUC of plasma glucose levels, maximum plasma glucose levels and postprandial blood glucose.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who routinely use health food containing large amount of fatty acids or health food for diet 2) Subjects routinely taking medicine or health food which may influence glucose metabolism 3) Subjects who have body mass index (BMI) less than 18.5 kg/square meter or more than 30.0 kg/square meter 4) Subjects who have fasting blood glucose more than 126 mg/dL on preliminary examination 5) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) 6) Subjects having possibilities for emerging allergy related to the current study 7) Subjects who are under medication or having a history of serious diseases for which medication was required 8) Subjects who are judged as unsuitable for the current study based on the results of clinical and physical preliminary examination 9) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 10) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating 11) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 12) Subjects judged as unsuitable for the study by the investigator for other reasons
研究者
相似试验
已完成
1 期
Does Hyaluronic Acid Affect Periodontal Treatment?PeriodontitisNCT03754010Yuzuncu Yıl University24
已完成
3 期
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social AnxietySocial Anxiety DisorderNCT00958880Southern Methodist University40
已完成
不适用
Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.Pregnancy, High RiskNCT04874285Lo.Li.Pharma s.r.l63
已完成
2 期
Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple SclerosisRelapsing-Remitting Multiple SclerosisNCT00390221Biogen621
终止
4 期
Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary CareDiabetes Mellitus, Type 2NCT00950534Sanofi25